Development of new nano-platforms for the treatment of triple negative ...
Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer. TNBC lacks the expression of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2) according to immunohistochemistry (IHC). TNBC is characterized by aggressive nature, high metastatic ability, lack of targeted therapy and high mortality ...